Symptoms
Five practice pointers for dispensing Paxlovid
Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 May. Here’s what pharmacists need to know.
Pharmacies destroyed and forced to close due to floods
As east coast residents wait for the floods to subside, pharmacists discuss the devastating impact on their homes, pharmacies and patients.
Making a difference in mental health
One in six Australians receive a mental health-related prescription each year.1 Almost half the population is set to experience a mental health condition in...
New list of banned drugs in sport released
The World Anti-Doping Agency (WADA) released an updated List of Prohibited Substances and Methods (the List).
The document, which is released annually, is part...
Responding to concerns about paracetamol use in pregnancy
As US regulators flag new warnings on paracetamol use, the TGA and Australian experts have weighed in on what the evidence shows.
Naloxone nasal spray added to the PBS
With increasing overdose deaths from both prescription opioids and heroin, naloxone nasal spray – now listed on the Pharmaceutical Benefits Scheme – is a...
